| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/17/2001 | EP1143806A2 Method for increasing pet activity |
| 10/17/2001 | EP1143805A2 Methods for reducing mortality rates in poultry |
| 10/17/2001 | EP1143799A1 Multi-purpose acid compositions |
| 10/17/2001 | EP1143796A1 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| 10/17/2001 | EP1143794A1 Lubrication composition |
| 10/17/2001 | EP1143793A1 Organoprotective solutions |
| 10/17/2001 | EP1039894B1 Compositions for increasing the concentration and/or motility of spermatozoa in humans |
| 10/17/2001 | EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 10/17/2001 | EP0999841B1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 10/17/2001 | EP0983265A4 Endothelin receptor antagonists |
| 10/17/2001 | EP0966281B1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure |
| 10/17/2001 | EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them |
| 10/17/2001 | EP0946497B1 Process for the preparation of nmda antagonists |
| 10/17/2001 | EP0942911B1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 10/17/2001 | EP0941063B1 Transdermal compositions containing levosimendan |
| 10/17/2001 | EP0877025B1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 10/17/2001 | EP0873110A4 Improved hemostatic composition for treating gingival area |
| 10/17/2001 | EP0842185B1 Ara-c derivatives |
| 10/17/2001 | EP0841930B1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 10/17/2001 | EP0833818B1 3-acylindoles as cb2 receptor agonists |
| 10/17/2001 | EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 10/17/2001 | EP0796251B1 Uracil derivatives |
| 10/17/2001 | EP0776201B1 Treating anxiety |
| 10/17/2001 | EP0769965B1 Aqueous risperidone formulations |
| 10/17/2001 | EP0759744B1 Narcotic containing aerosol formulation |
| 10/17/2001 | EP0754682B1 Aminostilbazole derivative and medicine |
| 10/17/2001 | EP0751766B1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 10/17/2001 | EP0664696B2 Sustained release compositions for treating periodontal disease |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | EP0650378B1 Treatment of physiological conditions with degassed perfluorocarbon liquid |
| 10/17/2001 | EP0641330B1 Gaba and l-glutamic acid analogs for antiseizure treatment |
| 10/17/2001 | EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 10/17/2001 | CN1318105A Methods for down-regulating osteoprotegerin ligand activity |
| 10/17/2001 | CN1318103A Nucleic acids and proteins from streptococcus pneumoniae |
| 10/17/2001 | CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation |
| 10/17/2001 | CN1318065A Novel salt form of pantoprazole |
| 10/17/2001 | CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity |
| 10/17/2001 | CN1318059A Isoquinolines as urokinase inhibitors |
| 10/17/2001 | CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors |
| 10/17/2001 | CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors |
| 10/17/2001 | CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 10/17/2001 | CN1318054A Novel compounds |
| 10/17/2001 | CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers |
| 10/17/2001 | CN1318052A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers |
| 10/17/2001 | CN1317979A Serotonergic 5HT2 agonists for treating glaucoma |
| 10/17/2001 | CN1317972A Compsn contg. rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 10/17/2001 | CN1317971A Antiviral combination comprising lamivudine and abacavir |
| 10/17/2001 | CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination |
| 10/17/2001 | CN1317969A Treatment of depression |
| 10/17/2001 | CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists |
| 10/17/2001 | CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P |
| 10/17/2001 | CN1317965A Compounds having IgE affecting properties |
| 10/17/2001 | CN1317964A Composition |
| 10/17/2001 | CN1317963A Composition |
| 10/17/2001 | CN1317962A Remedies for renal failure |
| 10/17/2001 | CN1317961A Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-releated diseases |
| 10/17/2001 | CN1317960A Pharmaceutical compsn. comprising D-i(chiro)-inositol for improving insulin sensitivity and glucose metabolism |
| 10/17/2001 | CN1317959A Multiple unit controlled non-independent release pharmaceutical preparations and method for preparing same |
| 10/17/2001 | CN1317952A Improved method for targeted topial treatment of disease |
| 10/17/2001 | CN1317938A Compsn. contg. neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-reated diseases |
| 10/17/2001 | CN1317937A Compsn. containing natural phenolic compound for preventing or treating elevated blood liquid level-related diseases |
| 10/17/2001 | CN1317571A Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B |
| 10/17/2001 | CN1317490A Novel-6-sulfamine-3-quinolyl phosphonate compounds, its prepn. process and medical compsn. contg. them |
| 10/17/2001 | CN1317489A Novel aryl radical or heteroaryl radical quinolyl phosphonate compounds, its preparing method and medical compsn. contg. them |
| 10/17/2001 | CN1317484A Fullerene derivative of E-isomer |
| 10/17/2001 | CN1317480A One-step process for synthetizing 2-oxazolidone derivative |
| 10/17/2001 | CN1317342A Eye preparation |
| 10/17/2001 | CN1317333A Chinese patent medicine for dropping off drug |
| 10/17/2001 | CN1317319A Ointment for treating bone injury and its preparing process |
| 10/17/2001 | CN1317314A Kelamycin injection and its preparing process |
| 10/17/2001 | CN1317313A Application of tea polyphenol in preparing medicine to suppress beta-amyloid aggregation and fibroplasia |
| 10/17/2001 | CN1317312A High-speed transcutaneous narcotic liquid |
| 10/17/2001 | CN1317311A Application of full-trans-tretinoin in preparing medicines to cure myocardial hypertrophy and vessel wall hyperplasia |
| 10/17/2001 | CN1317310A Method of preparing solid state creatine dosage and creatine dosage by same |
| 10/17/2001 | CN1317309A Instant oral medincinal preparation |
| 10/17/2001 | CN1073112C Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| 10/17/2001 | CN1073108C Texane derivatives having pyridil substituted C13 side chain, their prepn. and their use as anti-tumor agents |
| 10/17/2001 | CN1073106C Taxoids compound, preparation thereof, and pharmaceutical compsns. contg. same |
| 10/17/2001 | CN1073105C Semi-synthetic taxanes with anti-tumoural activity |
| 10/17/2001 | CN1073104C N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 10/17/2001 | CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity |
| 10/17/2001 | CN1073102C New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 10/17/2001 | CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 10/17/2001 | CN1073098C Benzothiazolone derivatives |
| 10/17/2001 | CN1073085C Process for prepn. O-desmethyl tramadol antimer |
| 10/17/2001 | CN1072959C Medicine for treating gastritis, gastric ulcer and duocenal ulcer and its prepn. method |
| 10/17/2001 | CN1072957C Externally-used medicine for pharyngitis |
| 10/17/2001 | CN1072953C Medicine for treating digestive system diseases and its prepn. method |
| 10/17/2001 | CN1072935C Prepn. method for medical compsns. contg. aza-steroid compound for treating prostatic hyperplasia |
| 10/17/2001 | CN1072934C Pharmaceutical emulsion |
| 10/17/2001 | CN1072933C Albendazole suspension for expelling and controlling parasite in livestock, and prepn. process thereof |
| 10/17/2001 | CN1072932C Method of preventing emesis and treating sexual dyfunction using tetra hydrobenz [CD] indole-6-carboxamides |
| 10/17/2001 | CN1072931C Method of inhibiting cell-cell adhesion |
| 10/17/2001 | CN1072930C Compsn. comrising tramadol material and non-steriodal anti-inflammatory drug |
| 10/17/2001 | CN1072929C Transdermal system for simultaneous delivery of a number of active principles |
| 10/17/2001 | CA2343843A1 Therapeutic light source and method |
| 10/16/2001 | USRE37410 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 10/16/2001 | US6303819 Sodium channel-blocking agent; chronic or neuropathic pain. |
| 10/16/2001 | US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof. |
| 10/16/2001 | US6303793 Intermediates for cyclin-dependent kinase inhibitors |